chr19-49861227-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_007254.4(PNKP):​c.*21A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00721 in 1,489,272 control chromosomes in the GnomAD database, including 71 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0048 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0075 ( 70 hom. )

Consequence

PNKP
NM_007254.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.03

Publications

2 publications found
Variant links:
Genes affected
PNKP (HGNC:9154): (polynucleotide kinase 3'-phosphatase) This locus represents a gene involved in DNA repair. In response to ionizing radiation or oxidative damage, the protein encoded by this locus catalyzes 5' phosphorylation and 3' dephosphorylation of nucleic acids. Mutations at this locus have been associated with microcephaly, seizures, and developmental delay.[provided by RefSeq, Sep 2010]
PNKP Gene-Disease associations (from GenCC):
  • ataxia - oculomotor apraxia type 4
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, Laboratory for Molecular Medicine
  • microcephaly, seizures, and developmental delay
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Charcot-Marie-Tooth disease type 2B2
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 19-49861227-T-G is Benign according to our data. Variant chr19-49861227-T-G is described in ClinVar as [Benign]. Clinvar id is 329890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00481 (733/152288) while in subpopulation SAS AF = 0.0155 (75/4830). AF 95% confidence interval is 0.0127. There are 1 homozygotes in GnomAd4. There are 369 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 70 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PNKPNM_007254.4 linkc.*21A>C 3_prime_UTR_variant Exon 17 of 17 ENST00000322344.8 NP_009185.2 Q96T60-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PNKPENST00000322344.8 linkc.*21A>C 3_prime_UTR_variant Exon 17 of 17 1 NM_007254.4 ENSP00000323511.2 Q96T60-1

Frequencies

GnomAD3 genomes
AF:
0.00481
AC:
732
AN:
152170
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00145
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0153
Gnomad FIN
AF:
0.00415
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00690
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00661
AC:
1643
AN:
248644
AF XY:
0.00763
show subpopulations
Gnomad AFR exome
AF:
0.00160
Gnomad AMR exome
AF:
0.00321
Gnomad ASJ exome
AF:
0.00340
Gnomad EAS exome
AF:
0.000382
Gnomad FIN exome
AF:
0.00551
Gnomad NFE exome
AF:
0.00661
Gnomad OTH exome
AF:
0.00607
GnomAD4 exome
AF:
0.00748
AC:
10001
AN:
1336984
Hom.:
70
Cov.:
20
AF XY:
0.00785
AC XY:
5270
AN XY:
671666
show subpopulations
African (AFR)
AF:
0.00142
AC:
44
AN:
30906
American (AMR)
AF:
0.00334
AC:
149
AN:
44586
Ashkenazi Jewish (ASJ)
AF:
0.00322
AC:
82
AN:
25436
East Asian (EAS)
AF:
0.000128
AC:
5
AN:
39112
South Asian (SAS)
AF:
0.0186
AC:
1556
AN:
83784
European-Finnish (FIN)
AF:
0.00520
AC:
275
AN:
52840
Middle Eastern (MID)
AF:
0.00632
AC:
33
AN:
5220
European-Non Finnish (NFE)
AF:
0.00749
AC:
7477
AN:
998880
Other (OTH)
AF:
0.00676
AC:
380
AN:
56220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
511
1022
1534
2045
2556
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
284
568
852
1136
1420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00481
AC:
733
AN:
152288
Hom.:
1
Cov.:
32
AF XY:
0.00495
AC XY:
369
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00144
AC:
60
AN:
41574
American (AMR)
AF:
0.00340
AC:
52
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3470
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5170
South Asian (SAS)
AF:
0.0155
AC:
75
AN:
4830
European-Finnish (FIN)
AF:
0.00415
AC:
44
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00690
AC:
469
AN:
68006
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
40
81
121
162
202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00302
Hom.:
0
Bravo
AF:
0.00457
Asia WGS
AF:
0.00375
AC:
13
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Microcephaly, seizures, and developmental delay Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
0.012
DANN
Benign
0.78
PhyloP100
-2.0
PromoterAI
0.083
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201872477; hg19: chr19-50364484; API